[Cardiogenic shock is a rare disease: the dedicated network]

Serafina Valente1, Marco Marini2, Ilaria Battistoni3

  • 1S.O.D. Interventistica Cardiologica Strutturale, AOU Careggi, Firenze - Area Emergenza-Urgenza ANMCO.

Giornale Italiano Di Cardiologia (2006)
|November 7, 2017
PubMed

Insights

Cardiogenic shock (CS) requires rapid diagnosis and aggressive treatment. This review outlines creating a CS network to ensure consistent, high-quality care for all patients, aiming to improve outcomes for this rare condition.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Health Systems Management

Background:

  • Cardiogenic shock (CS) is a rare but severe condition with persistently high mortality rates.
  • Current treatment approaches for CS often involve limited use of circulatory assistance and specialized centers.
  • Existing guidelines emphasize early diagnosis, prompt pharmacological support, and intensive care for CS patients.

Purpose of the Study:

  • To provide guidelines for establishing a dedicated Cardiogenic Shock (CS) network.
  • To identify essential components for creating a CS network within existing health regulations.
  • To promote equitable access to optimal care for all CS patients.

Main Methods:

  • Review of current epidemiological data and clinical registries on CS.
  • Analysis of expert recommendations and consensus documents regarding CS management.
  • Development of a framework for a structured CS care network.

Main Results:

  • CS necessitates a multidisciplinary, goal-oriented treatment strategy.
  • The establishment of specialized CS networks is crucial for improving patient outcomes.
  • Standardized protocols and resource allocation are key elements for effective CS care.

Conclusions:

  • A coordinated CS network approach is vital for managing this high-mortality condition.
  • Implementing a CS network ensures standardized, evidence-based care across different healthcare settings.
  • This framework aims to enhance treatment opportunities and outcomes for patients with cardiogenic shock.

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
395
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
645
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
937
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540